anmeldenSPI
20.149,63
PKT
+38,43
PKT
+0,19
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.05.14 | UBS overweight | Morgan Stanley | |
| 30.04.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 30.04.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 30.04.14 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 30.04.14 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 30.04.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.04.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 30.04.14 | Swiss Re overweight | Morgan Stanley | |
| 30.04.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 29.04.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 29.04.14 | Swiss Re Neutral | BNP PARIBAS | |
| 29.04.14 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 29.04.14 | Novartis Underweight | Morgan Stanley | |
| 29.04.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 28.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 25.04.14 | Holcim market-perform | Bernstein Research | |
| 25.04.14 | Holcim market-perform | Bernstein Research | |
| 25.04.14 | Novartis Hold | Deutsche Bank AG | |
| 25.04.14 | Holcim buy | UBS AG | |
| 24.04.14 | Novartis Halten | Independent Research GmbH | |
| 24.04.14 | UBS Hold | Commerzbank AG | |
| 24.04.14 | Novartis buy | UBS AG | |
| 24.04.14 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.04.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.04.14 | Novartis buy | S&P Capital IQ | |
| 23.04.14 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 23.04.14 | Novartis Underweight | Barclays Capital | |
| 23.04.14 | Novartis buy | UBS AG | |
| 23.04.14 | Novartis Hold | Deutsche Bank AG | |
| 22.04.14 | UBS buy | S&P Capital IQ | |
| 22.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 22.04.14 | BB Biotech buy | equinet AG | |
| 17.04.14 | UBS buy | Citigroup Corp. | |
| 17.04.14 | UBS Hold | Kelper Cheuvreux | |
| 17.04.14 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 17.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.04.14 | UBS buy | UBS AG | |
| 17.04.14 | BB Biotech kaufen | Independent Research GmbH |
